Totals
- Total revenue
- $344,379
- Total expenses
- $125,913
- Contributions and grants received
- $322,850
- Grants paid
- $60,267
- Program service revenue
- $0
- Investment income
- $21,529
- Other revenue
- $0
- Total assets, end of year
- $795,941
- Total liabilities, end of year
- $154
- Net assets or fund balances, end of year
- $795,787
- Program services expenses (Part IX)
- $77,489
- Management and general expenses
- $4,275
- Fundraising expenses
- $44,149
- Program service expenses (Part III)
- $77,489
Program services were 61.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$322,850
-
3 · Investment income
total $21,529 · excluded $21,529
-
8c · Net income from fundraising events
total $0
Functional expenses
Part IX, the statement of functional expenses.
-
2 · Grants to domestic individuals
total $60,267 · program services $60,267
-
11c · Fees: accounting
total $16 · management and general $16
-
11f · Fees: investment management
total $4,030 · management and general $4,030
-
11g · Fees: other
total $9,803 · program services $9,803
-
12 · Advertising and promotion
total $15,591 · program services $2,296 · fundraising $13,295
-
13 · Office expenses
total $227 · management and general $227
-
14 · Information technology
total $7,489 · program services $1,941 · fundraising $5,548
-
17 · Travel
total $3,182 · program services $3,182
-
23 · Insurance
total $260 · fundraising $260
-
24a · Other expenses: POSTAGE AND SHIPPING
total $3,060 · fundraising $3,060
-
24b · Other expenses: EVENT RENTAL
total $1,100 · fundraising $1,100
-
24c · Other expenses: TSHIRTS AND MERCHANDISE
total $19,706 · fundraising $19,706
-
24d · Other expenses: RAFFLE
total $1,180 · fundraising $1,180
-
24e · All other expenses
total $2 · management and general $2
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $125,514 · end of year $305,156
-
11 · Investments: publicly traded securities
beginning of year $453,286 · end of year $490,785
-
17 · Accounts payable and accrued expenses
beginning of year $1,479 · end of year $154
-
31 · Retained earnings, endowment or other funds
beginning of year $577,321 · end of year $795,787
Mission and programs · 2024
Mission
PROVIDE SUPPORT FOR STAGE 1 CLINICAL TRIALS FOR NEUROBLASTOMA AND DIRECT SUPPORT TO FAMILIES BATTLING THE DISEASE.
-
PROVIDED SUPPORT FOR STAGE 1 CLINICAL TRIALS FOR NEUROBLASTOMA AND DIRECT SUPPORT TO FAMILIES BATTLING THE DISEASE.
Expenses $77,489 · Grants $60,267 · Revenue $322,850
As filed on the 2024 return.
Listed in Part VII
-
John WelbournJOHN WELBOURN
PRESIDENT
- Total calculated
- $0
- Hours/week
- 0
-
Kate WelbournKATE WELBOURN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0
-
Heather DebruinHEATHER DEBRUIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0
-
Scott DebruinSCOTT DEBRUIN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 15 October 2025
- IRS schema version
- 2024v5.2
- Source object
- 202532889349301708
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.